Efficacy of SGLT2 inhibitors for the reduction of cardiovascular death and heart failure hospitalization among non-diabetic heart failure patients: a meta-analysis
Event:
Heart Failure 2023
Topic:
Pharmacotherapy
Session:
ePosters in chronic heart failure - pharmacotherapy 2
